Metagenomi Therapeutics, Inc.
MGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001785279
In the last 90 days, Metagenomi Therapeutics, Inc. insiders filed 1 open-market purchase and 3 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $7.45M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Metagenomi Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −4 vs. Q1 2026
- Shares held
- 6.26M
- −201.3K (−3.1%) vs. Q1 2026
- Total value
- $7.45M
- −$1.20M (−13.9%) vs. Q1 2026
- New holders
- 4
- 12 more added
- Sold out
- 8
- 13 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $7.45M |
| Q1 2026 | 48 | $8.65M |
| Q4 2025 | 56 | $11.1M |
| Q3 2025 | 58 | $14.3M |
| Q2 2025 | 69 | $10.4M |
| Q1 2025 | 79 | $13.5M |
| Q4 2024 | 77 | $38.9M |
| Q3 2024 | 67 | $25.3M |
| Q2 2024 | 54 | $49.6M |
| Q1 2024 | 50 | $140.6M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Metagenomi Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,077,700 | $1.28M | 0.00% | +19,756+1.9% | Added |
| Renaissance Technologies LLC | 742,400 | $883.5K | 0.00% | −45,500−5.8% | Reduced |
| Catalio Capital Management, LP | 528,993 | $629.5K | 0.12% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 525,024 | $624.8K | 0.42% | +8,263+1.6% | Added |
| Two Sigma Investments, LP | 513,701 | $611.3K | 0.00% | +16,934+3.4% | Added |
| Bridgeway Capital Management, LLC | 400,300 | $476.4K | 0.01% | +4,500+1.1% | Added |
| Wells Fargo & Company | 379,508 | $451.6K | 0.00% | +177,370+87.7% | Added |
| Geode Capital Management, LLC | 288,665 | $343.7K | 0.00% | −69,535−19.4% | Reduced |
| Pura Vida Investments, LLC | 264,391 | $314.6K | 0.85% | 00.0% | Unchanged |
| BlackRock, Inc. | 257,631 | $306.6K | 0.00% | +27,497+11.9% | Added |
| Vanguard Fiduciary Trust Co | 171,251 | $203.8K | 0.00% | +1,077+0.6% | Added |
| Jacobs Levy Equity Management, Inc | 160,000 | $190.4K | 0.00% | −222,153−58.1% | Reduced |
| State Street Corp | 119,850 | $142.6K | 0.00% | −577−0.5% | Reduced |
| Millennium Management LLC | 114,025 | $135.7K | 0.00% | −56,079−33.0% | Reduced |
| Man Group plc | 109,130 | $129.9K | 0.00% | +30,494+38.8% | Added |
| Resolute Partners Group | 89,944 | $107.0K | 0.03% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 72,121 | $85.8K | 0.01% | +72,121 | New |
| Northern Trust Corp | 68,938 | $82.0K | 0.00% | −6,234−8.3% | Reduced |
| RBF Capital, LLC | 64,021 | $76.2K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 55,707 | $66.3K | 0.00% | +15,125+37.3% | Added |
| BBR Partners, LLC | 53,403 | $63.5K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 38,396 | $45.7K | 0.00% | −113,044−74.6% | Reduced |
| Fortitude Advisory Group L.L.C. | 37,190 | $44.3K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 17,851 | $21.2K | 0.00% | +858+5.0% | Added |
| Qube Research & Technologies Ltd | 16,850 | $20.1K | 0.00% | +16,850 | New |
| UBS Group AG | 15,793 | $18.8K | 0.00% | −305−1.9% | Reduced |
| Two Sigma Securities, LLC | 15,173 | $18.1K | 0.00% | +15,173 | New |
| Vanguard Global Advisers, LLC | 13,392 | $15.9K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 12,797 | $15.2K | 0.00% | 00.0% | Unchanged |
| Peak Planning Group, LLC | 12,500 | $14.9K | 0.00% | 00.0% | Unchanged |
| Meeder Asset Management Inc | 5,496 | $6.54K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,302 | $6.31K | 0.00% | −22,264−80.8% | Reduced |
| Tower Research Capital LLC (TRC) | 5,300 | $6.31K | 0.00% | +5,258+12,519.0% | Added |
| US Bancorp | 4,500 | $5.36K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,891 | $2.25K | 0.00% | −1,000−34.6% | Reduced |
| JPMorgan Chase & Co | 1,596 | $1.92K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 588 | $700 | 0.00% | −4,130−87.5% | Reduced |
| Jones Financial Companies LLLP | 500 | $625 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 500 | $595 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 207 | $246 | 0.00% | −100−32.6% | Reduced |
| Barclays PLC | 167 | $199 | 0.00% | +167 | New |
| Caitong International Asset Management Co., Ltd | 8 | $10 | 0.00% | +4+100.0% | Added |
| Optiver Holding B.V. | 2 | $2 | 0.00% | −16−88.9% | Reduced |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −27,521−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −16,834−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −11,726−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,674−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −4,179−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −511−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −314−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |